Trimix with Atropine Injectable 30 mg/3 mg/300 mcg/0 recalled over sterility concerns
- Recall date
- September 21, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Wells Pharmacy Network LLC recalls Trimix with Atropine Injectable 30 mg/3 mg/300 mcg/0.2 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL
- Recall number
- D-0410-2017
- FDA classification
- Class II
- Brand / firm
- Wells Pharmacy Network LLC
- Sold / distributed
- Nationwide
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Trimix with Atropine Injectable 30 mg/3 mg/300 mcg/0.2 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL
Get recall alerts
Free email alert whenever Wells Pharmacy Network LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Wells Pharmacy Network LLC